ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Ultrasound Reported Accurate in Screen For Prostate Cancer

April 25, 1986

OCC Has Answers Ready Or Most Questions Asked

March 21, 1980

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

April 25, 2014

Lung Screening Study Ties Up Advisors, Board Sends It Back To NCI For Revision.

June 29, 2001

FDA’s Jane Henney

February 11, 1994

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983